Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: A subanalysis of the IRIS study

Richard A. Larson, Brian J. Druker, Francois Guilhot, Stephen G. O'Brien, Gilles J. Riviere, Tillmann Krahnke, Insa Gathmann, Yanfeng Wang

Research output: Contribution to journalArticlepeer-review

496 Scopus citations

Fingerprint

Dive into the research topics of 'Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: A subanalysis of the IRIS study'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds